Does ERTUGLIFLOZIN PIDOLATE Cause Decreased appetite? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Decreased appetite have been filed in association with ERTUGLIFLOZIN PIDOLATE (STEGLATRO). This represents 1.0% of all adverse event reports for ERTUGLIFLOZIN PIDOLATE.
7
Reports of Decreased appetite with ERTUGLIFLOZIN PIDOLATE
1.0%
of all ERTUGLIFLOZIN PIDOLATE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Decreased appetite From ERTUGLIFLOZIN PIDOLATE?
Of the 7 reports, 5 (71.4%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTUGLIFLOZIN PIDOLATE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ERTUGLIFLOZIN PIDOLATE Cause?
Fungal infection (58)
Product dose omission issue (57)
Nausea (55)
No adverse event (53)
Urinary tract infection (52)
Diabetic ketoacidosis (34)
Dizziness (33)
Vomiting (31)
Blood glucose increased (30)
Product dose omission (27)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ERTUGLIFLOZIN PIDOLATE Alternatives Have Lower Decreased appetite Risk?
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROPOIETIN
ERTUGLIFLOZIN PIDOLATE vs ESCHERICHIA COLI